Kuopio, Finland – July 1, 2025 Dr. Shatillo brings extensive expertise in scientific leadership, digitalization, and operational development within the preclinical research sector. With a multidisciplinary background that combines medical training, neuroscience, and software development, he is uniquely positioned to lead Experimentica’s digital transformation efforts.

In his new role, Dr. Shatillo will be responsible for advancing the company’s digital strategy, optimizing core processes, implementing automation and AI-based tools, and enhancing data-driven decision-making across all functions. He will also oversee IT infrastructure, ensure compliance with digital regulations, and lead change management initiatives that support sustainable growth.

His appointment reflects Experimentica’s ongoing commitment to scientific excellence, premium quality research outcomes, and flexibility. By embedding advanced digital tools and processes into our operations, Dr. Shatillo will further support the delivery of highly reproducible results, elevate the precision of our research, and strengthen our ability to offer tailored, client-centric solutions.

“We are thrilled to have Artem join our leadership team. His experience at the intersection of science, technology, and business transformation aligns seamlessly with our strategic direction. I am confident that Artem’s forward-thinking approach will accelerate our digital evolution and further strengthen our commitment to innovation and operational excellence.”

Jukka Puoliväli, Managing Director,

Experimentica Ltd.

Known for his analytical mindset and solution-oriented leadership style, Dr. Shatillo has successfully led multiple large-scale digitalization and process improvement projects, developed AI-driven tools for scientific applications, and championed initiatives that have enhanced operational efficiency and client service.

“It is a great honor to join Experimentica at such a dynamic time in its journey,” said Dr. Shatillo. “I look forward to working with the team to integrate smart digital solutions that support both scientific excellence and business agility, while ensuring we continue to deliver high-quality, flexible research services to our clients.”

For more information about Experimentica Ltd. and its latest developments, please contact:
Guillaume Demarne, PharmD
Chief Business Officer
gd@experimentica.com
+33 7 83 55 69 52

About Experimentica Ltd.

At Experimentica, we help drug development teams advance safe and effective ocular therapies from discovery to the clinic. Our preclinical ophthalmic experts work closely with customers throughout their projects, offering tailored scientific guidance and support. With state-of-the-art technologies, proprietary algorithms, and AI-driven analysis, we deliver comprehensive data and actionable insights to accelerate decision-making and development.

About Dr. Artem Shatillo

Dr. Artem Shatillo has a multidisciplinary background, holding a Medical Doctor degree in Psychiatry (2005), software development training (2006), and doctoral training in Imaging and Neurobiology from the University of Eastern Finland (2009-2015). In 2015 he joined the preclinical CRO industry as Senior Manager of Imaging and later Research Leader at Charles River Discovery Services. He pioneered AI/ML-based tools for digital image analysis, brought to market a functional neuroimaging product line, and led digital transformation initiatives across multiple company sites. Trained in Lean Six Sigma and Evidence-Based Management, Dr. Shatillo transforms complex scientific workflows into streamlined, data-driven operations, earning him recognition as both an innovator and a continuous improvement champion.

Guillaume Demarne

Guillaume Demarne

, PharmD

Chief Business Officer